Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1b study of ZP9830 in plaque psoriasis
NL-OMON61320Phase 1Recruiting
- Sponsor
- Zealand Pharma
- Start
- Jul 2026
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 1 trial of ZP9830 in plaque psoriasis, sponsored by Zealand Pharma. Primary endpoint: Primary endpoint(s). Started Jul 2026; status: recruiting.
02
Drugs
ZP9830
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NL-OMON61320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON61320.